Number of COVID-19 cases required in a population to detect SARS-CoV-2 RNA in wastewater in the province of Alberta, Canada: Sensitivity assessmentResearch article Published on 2023-03-012022-10-05 Journal: Journal of environmental sciences (China) [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] analysis Analysis collected Community COVID-19 COVID-19 case COVID-19 cases Critical dataset defined detect detection rate Detection sensitivity Epidemiology Estimated IMPROVE input median negative test number plant positive prevalence of COVID-19 Probability Probit analysis provided required RT-qPCR SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 RNA detection sensitivity study period Support Surveillance threshold Treatment unique wastewater [DOI] 10.1016/j.jes.2022.04.047 [Article Type] Research article
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021Article Published on 2022-11-012022-11-15 Journal: Influenza and Other Respiratory Viruses [Category] COVID19(2023년), SARS, 진단, [키워드] absence age Anti-nucleocapsid antibodies antibody automatically children collected conducted confirmed COVID-19 case contributed COVID-19 COVID-19 case COVID-19 pandemic COVID-19 vaccination CrI cross-sectional cumulative estimate Estimated flow cytometric IgG antibody individual Infection Laboratory National Norway nucleocapsid nucleocapsid protein Prevalence RBD Receptor binding domain registry data residual SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 seroprevalence sera seropositive sample Seroprevalence the spike protein vaccination vaccination. were measured women [DOI] 10.1111/irv.13024 PMC 바로가기
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access ProgramArticle Published on 2022-10-032022-11-15 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 진단, [키워드] Capacity clinical COVID-19 Estimated Expanded Access Program Site [DOI] 10.1001/jamanetworkopen.2022.37540 PMC 바로가기
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI adjusted Against age Care case-control study conducted dose doses Estimated female genomic greater Health Heterologous Hospitalization individual individuals Infection laboratory-confirmed laboratory-confirmed SARS-CoV-2 infection messenger Messenger RNA mRNA mRNA vaccination mRNA vaccine Odds ratio Older omicron outcome participant Participants phylogenetically Postinfection Prevent protection provided quantification Quebec, Canada reduction Reinfection risk risk reduction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severity Sex significantly higher stratified Surveillance tested vaccinated individual vaccination Vaccine vaccine dose vaccine strain variant [DOI] 10.1001/jamanetworkopen.2022.36670 PMC 바로가기
Estimation of the Serial Interval and the Effective Reproductive Number of COVID-19 Outbreak Using Contact Data in Burkina Faso, a Sub-Saharan African CountryArticle Published on 2022-09-252022-11-16 Journal: Computational and Mathematical Methods in Medicine [Category] SARS, 치료기술, [키워드] African analyzed basic reproductive number Cluster Contact tracing country COVID-19 COVID-19 outbreak decrease distribution effective Estimated estimation index case Infection information interval less MONITOR novel coronavirus disease number outbreak parameter reproductive Spread the epidemic Transmission [DOI] 10.1155/2022/8239915 PMC 바로가기
Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samplesArticle Published on 2022-09-022022-11-15 Journal: PLoS ONE [Category] SARS, 치료기술, [키워드] Antenatal anti-RBD antibody binding domain community transmission Critical death Deprivation determine Effect Estimated Evidence groups hospitalisation incidence London NHS Outbreaks pandemic peaked Prevalence quantified reflect resource risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor serum sample serum samples significant interaction tested the SARS-CoV-2 virus Transmission dynamics [DOI] 10.1371/journal.pone.0273966 PMC 바로가기
Self-administered, remote assessment of SARS-CoV-2 seroprevalence in health care workersArticle Published on 2022-09-012022-11-15 Journal: The American journal of the medical sciences [Category] SARS, 진단, [키워드] clinician Cohort Community conducted Control enrolled Estimated Evidence Health care worker health care workers identify IgG immunoassay Infection infection rate lateral flow not differ Nurse point-of-care reported SARS-COV-2 infection SARS-CoV-2 nucleocapsid SARS-CoV-2 seroprevalence serologic testing seropositive subject the epidemic was performed widespread [DOI] 10.1016/j.amjms.2022.01.025 PMC 바로가기
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United StatesArticle Published on 2022-09-012022-11-16 Journal: JAMA Network Open [Category] SARS, 변종, 유전자 메커니즘, [키워드] 95% CI adjusted odds ratio Against age black booster dose calculated Care case-control study conducted COVID-19 COVID-19 vaccination COVID-19 vaccine Delta delta variant dose Effectiveness eligible estimate Estimated estimation evaluate high risk Hispanic hospital Hospitalization hospitalizations IQR laboratory-confirmed molecular mRNA mRNA vaccination mRNA vaccine omicron outcome Patient Period positive Pregnancy pregnant protection SARS-CoV-2 severe COVID-19 the median the United State variant waned were excluded [DOI] 10.1001/jamanetworkopen.2022.33273 PMC 바로가기
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe OutcomesArticle Published on 2022-09-012022-11-16 Journal: JAMA Network Open [Category] SARS, 변종, [키워드] 95% CI administration Against age calculated Canada case-control study Control COVID-19 COVID-19 symptom COVID-19 vaccination COVID-19 vaccine database death Delta delta variant disease dose Effectiveness Estimated female Health Hospitalization incidence individual Infection infections Laboratory testing Logistic regression Older omicron outcome outcomes participant Participants Preventing receipt SARS-CoV-2 SARS-COV-2 infection second dose symptomatic symptomatic infection tested understanding vaccination Vaccine Vaccines variant variants was used [DOI] 10.1001/jamanetworkopen.2022.32760 PMC 바로가기
Fatality assessment and variant risk monitoring for COVID-19 using three new hospital occupancy related metricsResearch article Published on 2022-09-012022-10-05 Journal: EBioMedicine [Category] SARS, 변종, 유전자 메커니즘, 치료기술, [키워드] analyses average Case fatality rate (CFR) caused CFR changes in country COVID-19 COVID-19 hospitalization COVID-19 severity death described discharge early stage Estimated fatality Fatality rate finding funding hospital Hospital mortality Hospital occupancy mortality rate (HOMR) mathematical Metrics mortality rate Multiple omicron pandemic Range-to-mean ratio (R/M) Ratio of hospital occupancy to cases (HOCR) Ratio of total deaths to hospital occupancy (TDHOR) risk severity of COVID-19 variant Variation were used [DOI] 10.1016/j.ebiom.2022.104225 [Article Type] Research article